Alpha 2.0
Login Register
» Authors » Simona Puzelli

Simona Puzelli

Explore the profile of Simona Puzelli including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 43
Citations 1029
Followers 0
Related Specialties
Microbiology
Infectious Diseases
Allergy & Immunology
Top 10 Co-Authors
Isabella Donatelli
Marzia Facchini
Antonino Bella
Caterina Rizzo
Concetta Fabiani
Giovanni Rezza
Laura Campitelli
Angela Di Martino
Livia Di Trani
Laura Calzoletti
Published In
J Med Virol
Vaccine
PLoS One
Emerg Infect Dis
J Gen Virol
Affiliations
Soon will be listed here.
Recent Articles
1.
A Serum Multi-Parametric Analysis Identifies an Early Innate Immune Signature Associated to Increased Vaccine-Specific Antibody Production and Seroconversion in Simultaneous COVID-19 mRNA and Cell-Based Quadrivalent Influenza Vaccination
Severa M, Ricci D, Etna M, Facchini M, Puzelli S, Fedele G, et al.
Vaccines (Basel) . 2024 Sep; 12(9). PMID: 39340080
In this pilot study, a multi-parametric analysis comparing immune responses in sera of adult healthy subjects (HS) or people with type 2 diabetes mellitus (T2D) undergoing the single or simultaneous...
2.
Characterization of an influenza B virus isolated from a fatal case of myocarditis in a pediatric patient in Italy
Puzelli S, Facchini M, Piacentini S, Di Mario G, Colucci M, Calzoletti L, et al.
J Infect Public Health . 2024 Jan; 17(3):417-420. PMID: 38262078
Influenza B is one of the infective agents that can cause rapid and fatal myocarditis in children. Here, we describe a fatal case of myocarditis in a previously healthy child,...
3.
Identification of Anti-Influenza A Compounds Inhibiting the Viral Non-Structural Protein 1 (NS1) Using a Type I Interferon-Driven Screening Strategy
Marsili G, Acchioni C, Remoli A, Amatore D, Sgarbanti R, De Angelis M, et al.
Int J Mol Sci . 2023 Jul; 24(13). PMID: 37445672
There is an urgent need to identify efficient antiviral compounds to combat existing and emerging RNA virus infections, particularly those related to seasonal and pandemic influenza outbreaks. While inhibitors of...
4.
Multiplex Real-Time Reverse-Transcription Polymerase Chain Reaction Assays for Diagnostic Testing of Severe Acute Respiratory Syndrome Coronavirus 2 and Seasonal Influenza Viruses: A Challenge of the Phase 3 Pandemic Setting
Mancini F, Barbanti F, Scaturro M, Fontana S, Di Martino A, Marsili G, et al.
J Infect Dis . 2020 Oct; 223(5):765-774. PMID: 33080031
Background: Pandemic coronavirus disease 2019 (COVID-19) disease represents a challenge for healthcare structures. The molecular confirmation of samples from infected individuals is crucial and therefore guides public health decision making....
5.
Moderate Vaccine Effectiveness against Severe Acute Respiratory Infection Caused by A(H1N1)pdm09 Influenza Virus and No Effectiveness against A(H3N2) Influenza Virus in the 2018/2019 Season in Italy
Rizzo C, Gesualdo F, Loconsole D, Pandolfi E, Bella A, Orsi A, et al.
Vaccines (Basel) . 2020 Aug; 8(3). PMID: 32751584
Every season, circulating influenza viruses change; therefore, vaccines must be reformulated each year. We aimed to estimate vaccine effectiveness (VE) against severe influenza infection for the 2018/19 season in Italy....
6.
Co-circulation of the two influenza B lineages during 13 consecutive influenza surveillance seasons in Italy, 2004-2017
Puzelli S, Di Martino A, Facchini M, Fabiani C, Calzoletti L, Di Mario G, et al.
BMC Infect Dis . 2019 Nov; 19(1):990. PMID: 31752738
Background: Since 1985, two antigenically distinct lineages of influenza B viruses (Victoria-like and Yamagata-like) have circulated globally. Trivalent seasonal influenza vaccines contain two circulating influenza A strains but a single...
7.
Moderate influenza vaccine effectiveness against A(H1N1)pdm09 virus, and low effectiveness against A(H3N2) subtype, 2018/19 season in Italy
Bellino S, Bella A, Puzelli S, Di Martino A, Facchini M, Punzo O, et al.
Expert Rev Vaccines . 2019 Nov; 18(11):1201-1209. PMID: 31674847
: Influenza vaccines are updated every year to match the vaccine strains with currently circulating viruses; consequently influenza vaccine effectiveness (IVE) has to be assessed annually.: A test-negative case-control study...
8.
Virological Surveillance of Influenza in the eight epidemic seasons after the 2009 pandemic in Emilia-Romagna (Northern Italy)
Affanni P, Colucci M, Bracchi M, Capobianco E, Zoni R, Caruso L, et al.
Acta Biomed . 2019 Sep; 90(9-S):35-44. PMID: 31517888
Background And Aim Of The Work: Influenza virological surveillance is essential for monitoring the evolution of influenza viruses (IVs) as well as for annual updating of the vaccine composition. The...
9.
Distribution of influenza virus types by age using case-based global surveillance data from twenty-nine countries, 1999-2014
Caini S, Spreeuwenberg P, Kusznierz G, Rudi J, Owen R, Pennington K, et al.
BMC Infect Dis . 2018 Jun; 18(1):269. PMID: 29884140
Background: Influenza disease burden varies by age and this has important public health implications. We compared the proportional distribution of different influenza virus types within age strata using surveillance data...
10.
Improving influenza virological surveillance in Europe: strain-based reporting of antigenic and genetic characterisation data, 11 European countries, influenza season 2013/14
Broberg E, Hungnes O, Schweiger B, Prosenc K, Daniels R, Guiomar R, et al.
Euro Surveill . 2016 Oct; 21(41). PMID: 27762211
Influenza antigenic and genetic characterisation data are crucial for influenza vaccine composition decision making. Previously, aggregate data were reported to the European Centre for Disease Prevention and Control by European...